Psychemedics Corporation (PMD)

NASDAQ: PMD · IEX Real-Time Price · USD

2.705

+0.105 (4.04%)

At close: Apr 18, 2024, 10:27 AM

2.560

-0.145 (-5.36%)

After-hours: Apr 18, 2024, 4:00 PM EDT

Psychemedics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1994
Net Income	-4.15	-1.08	-0.67	-3.86	1.54	4.58	6.12	6.68	1.51	3.21	Upgrade
Depreciation & Amortization	2.67	3.32	3.69	3.63	2.91	3.06	2.81	2.29	1.73	1.05	Upgrade
Share-Based Compensation	0.91	0.87	0.74	0.56	0.76	0.59	0.58	0.67	0.67	0.61	Upgrade
Other Operating Activities	-0.9	1.79	-3.35	-4.41	-0.91	-0.31	-0.36	-0.37	0.66	-0.41	Upgrade
Operating Cash Flow	-1.48	4.89	0.41	-4.08	4.31	7.93	9.15	9.27	4.58	4.46	Upgrade
Operating Cash Flow Growth	-	1081.16%	-	-	-45.66%	-13.31%	-1.33%	102.38%	2.78%	-25.13%	Upgrade
Capital Expenditures	-0.16	-0.19	-0.18	-0.85	-1.68	-1.19	-1.25	-2.09	-1.8	-7.81	Upgrade
Change in Investments	0	0	0	0	3.81	-4.04	0	0	0	0	Upgrade
Other Investing Activities	-0	-0.02	-0.04	-0.01	-0.06	-0.13	-	-	-	-	Upgrade
Investing Cash Flow	-0.16	-0.21	-0.22	-0.86	2.08	-5.36	-1.25	-2.09	-1.8	-7.81	Upgrade
Dividends Paid	-0.8	-1.19	-0.28	-0.99	-3.97	-3.8	-3.29	-3.27	-3.24	-3.21	Upgrade
Share Issuance / Repurchase	-0.05	-0.07	-0.07	-0.01	-0.03	-0.09	-0.16	-0.15	-0.11	-0.04	Upgrade
Debt Issued / Paid	-0.29	-0.66	-0.69	1.5	1	-1.75	-0	-2.51	-0.36	6.25	Upgrade
Financing Cash Flow	-1.15	-1.92	-1.04	0.5	-3	-5.64	-3.46	-5.93	-3.71	2.99	Upgrade
Exchange Rate Effect	0	0	0	-0.01	-0.17	-1.03	-0.22	0	0	0	Upgrade
Net Cash Flow	-2.79	2.76	-0.84	-4.45	3.21	-4.1	4.23	1.25	-0.92	-0.36	Upgrade
Free Cash Flow	-1.64	4.7	0.23	-4.93	2.63	6.74	7.9	7.18	2.78	-3.35	Upgrade
Free Cash Flow Growth	-	1927.16%	-	-	-60.94%	-14.71%	10.10%	157.91%	-	-	Upgrade
Free Cash Flow Margin	-7.41%	18.63%	0.93%	-23.10%	6.99%	15.79%	19.90%	18.41%	10.31%	-11.48%	Upgrade
Free Cash Flow Per Share	-0.28	0.84	0.04	-0.89	0.48	1.23	1.44	1.32	0.52	-0.63	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).